386 related articles for article (PubMed ID: 32509277)
1. Recent advances in understanding and managing pediatric nonalcoholic fatty liver disease.
Vittorio J; Lavine JE
F1000Res; 2020; 9():. PubMed ID: 32509277
[TBL] [Abstract][Full Text] [Related]
2. Similarities and differences between pediatric and adult nonalcoholic fatty liver disease.
Crespo M; Lappe S; Feldstein AE; Alkhouri N
Metabolism; 2016 Aug; 65(8):1161-71. PubMed ID: 26961580
[TBL] [Abstract][Full Text] [Related]
3. Design and rationale for a real-world observational cohort of patients with nonalcoholic fatty liver disease: The TARGET-NASH study.
Barritt AS; Gitlin N; Klein S; Lok AS; Loomba R; Malahias L; Powell M; Vos MB; Weiss LM; Cusi K; Neuschwander-Tetri BA; Sanyal A
Contemp Clin Trials; 2017 Oct; 61():33-38. PubMed ID: 28735109
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice.
Zhou JH; Cai JJ; She ZG; Li HL
World J Gastroenterol; 2019 Mar; 25(11):1307-1326. PubMed ID: 30918425
[TBL] [Abstract][Full Text] [Related]
5. Emerging New Diagnostic Modalities and Therapies of Nonalcoholic Fatty Liver Disease.
Lin CH; Kohli R
Curr Gastroenterol Rep; 2020 Aug; 22(10):52. PubMed ID: 32814993
[TBL] [Abstract][Full Text] [Related]
6. Nonalcoholic fatty liver disease: a challenge for pediatricians.
Nobili V; Alkhouri N; Alisi A; Della Corte C; Fitzpatrick E; Raponi M; Dhawan A
JAMA Pediatr; 2015 Feb; 169(2):170-6. PubMed ID: 25506780
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease.
Satapathy SK; Sanyal AJ
Semin Liver Dis; 2015 Aug; 35(3):221-35. PubMed ID: 26378640
[TBL] [Abstract][Full Text] [Related]
8. Nonalcoholic Fatty Liver Disease in Children: Unique Considerations and Challenges.
Goldner D; Lavine JE
Gastroenterology; 2020 May; 158(7):1967-1983.e1. PubMed ID: 32201176
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From "two hit theory" to "multiple hit model".
Fang YL; Chen H; Wang CL; Liang L
World J Gastroenterol; 2018 Jul; 24(27):2974-2983. PubMed ID: 30038464
[TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic Liver Disease in Children and Adolescents.
Smith SK; Perito ER
Clin Liver Dis; 2018 Nov; 22(4):723-733. PubMed ID: 30266159
[TBL] [Abstract][Full Text] [Related]
11. Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
Watanabe S; Hashimoto E; Ikejima K; Uto H; Ono M; Sumida Y; Seike M; Takei Y; Takehara T; Tokushige K; Nakajima A; Yoneda M; Saibara T; Shiota G; Sakaida I; Nakamuta M; Mizuta T; Tsubouchi H; Sugano K; Shimosegawa T; ;
J Gastroenterol; 2015 Apr; 50(4):364-77. PubMed ID: 25708290
[TBL] [Abstract][Full Text] [Related]
12. Features of nonalcoholic steatohepatitis in severely obese children and adolescents undergoing sleeve gastrectomy.
Alqahtani A; Elahmedi M; Alswat K; Arafah M; Fagih M; Lee J
Surg Obes Relat Dis; 2017 Sep; 13(9):1599-1609. PubMed ID: 28600116
[TBL] [Abstract][Full Text] [Related]
13. Nonalcoholic steatohepatitis (NASH) - current treatment recommendations and future developments.
Roeb E; Geier A
Z Gastroenterol; 2019 Apr; 57(4):508-517. PubMed ID: 30965381
[TBL] [Abstract][Full Text] [Related]
14. [Overview of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis Management].
Kim SK; Kim KI; Kim SR
Yakugaku Zasshi; 2019; 139(9):1147-1153. PubMed ID: 31474630
[TBL] [Abstract][Full Text] [Related]
15. Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.
Younossi Z; Tacke F; Arrese M; Chander Sharma B; Mostafa I; Bugianesi E; Wai-Sun Wong V; Yilmaz Y; George J; Fan J; Vos MB
Hepatology; 2019 Jun; 69(6):2672-2682. PubMed ID: 30179269
[TBL] [Abstract][Full Text] [Related]
16. Impact of lifestyle interventions on pathogenesis of nonalcoholic fatty liver disease.
Ezzat WM
World J Gastroenterol; 2024 May; 30(20):2633-2637. PubMed ID: 38855152
[TBL] [Abstract][Full Text] [Related]
17. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
Takahashi Y; Fukusato T
World J Gastroenterol; 2014 Nov; 20(42):15539-48. PubMed ID: 25400438
[TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic fatty liver disease - current status and future directions.
Demir M; Lang S; Steffen HM
J Dig Dis; 2015 Oct; 16(10):541-57. PubMed ID: 26406351
[TBL] [Abstract][Full Text] [Related]
19. Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Younossi ZM; Loomba R; Rinella ME; Bugianesi E; Marchesini G; Neuschwander-Tetri BA; Serfaty L; Negro F; Caldwell SH; Ratziu V; Corey KE; Friedman SL; Abdelmalek MF; Harrison SA; Sanyal AJ; Lavine JE; Mathurin P; Charlton MR; Chalasani NP; Anstee QM; Kowdley KV; George J; Goodman ZD; Lindor K
Hepatology; 2018 Jul; 68(1):361-371. PubMed ID: 29222911
[TBL] [Abstract][Full Text] [Related]
20. Current Concepts in Pediatric Nonalcoholic Fatty Liver Disease.
Fleet SE; Lefkowitch JH; Lavine JE
Gastroenterol Clin North Am; 2017 Jun; 46(2):217-231. PubMed ID: 28506362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]